Skip to main content
. 2016 May 23;60(6):3840–3844. doi: 10.1128/AAC.00436-16

TABLE 2.

MIC distributions of tetracycline analogues for Enterobacteriaceae, excluding Proteeae, in relation to carbapenem resistance types

Drug and characteristic(s) (n) No. of isolates with characteristic(s) at MIC (μg/ml) ofa:
≤0.06 0.13 0.25 0.5 1 2 4 8 16 32 ≥64
Eravacycline
    KPC (45) 3 13 17 9 2 1
    VIM (44) 16 18 8 2
    IMP (15) 1 4 4 1 5
    NDM (42) 5 16 9 9 2 1
    OXA-48 (44) 2 18 15 5 2 2
    Porin loss + ESBL/AmpC (40) 1 13 10 8 5 3
    Susceptible controls (35) 2 9 10 11 3
    Carbapenemase positive chosen as Tigr (30) 2 4 4 4 6 9 1
Tigecycline
    KPC (45) 8 14 16 4 3
    VIM (44) 6 16 13 8 1
    IMP (15) 1 7 2 5
    NDM (42) 1 6 18 7 9 1
    OXA-48 (44) 7 22 10 2 2 1
    Porin loss + ESBL/AmpC (40) 5 11 12 5 5 2
    Susceptible controls (35) 1 10 15 9
    Carbapenemase-positive chosen as Tigr (30) 2 4 6 6 9 3
Minocycline
    KPC (45) 1 1 14 11 12 3 3
    VIM (44) 2 8 13 13 4 3 1
    IMP (15) 1 5 2 1 3 3
    NDM (42) 1 8 8 8 9 6 2
    OXA-48 (44) 2 14 13 7 3 3 2
    Porin loss + ESBL/AmpC (40) 1 6 13 7 5 6 2
    Susceptible controls (35) 2 11 14 6 2
    Carbapenemase positive chosen as Tigr (30) 1 2 4 6 4 13
Tetracycline
    KPC (45) 5 8 10 2 2 18b
    VIM (44) 1 8 3 1 31b
    IMP (15) 1 3 2 2 1 4 2b
    NDM (42) 4 4 7 1 26b
    OXA-48 (44) 8 12 6 3 2 13b
    Porin loss + ESBL/AmpC (40) 1 5 9 5 4 16b
    Susceptible controls (35) 5 13 12 2 2 1b
    Carbapenemase positive chosen as Tigr (30) 1 2 2 3 5 17b
a

MIC50s are underlined, and MIC90s are in boldface; in some cases, these values coincide.

b

The MIC is greater than or equal to the indicated value.